CCS Clinical Classifications - Medications (Injections, infusions and other forms)

Back To CCS List

The following table lists codes that belong to the Medications (Injections, infusions and other forms) Clinical Classification:

CodeDescription
HCPCS A4802Protamine sulfate, for hemodialysis, per 50 mg
HCPCS A9150Non-prescription drugs
HCPCS A9152Single vitamin/mineral/trace element, oral, per dose, not otherwise specified
HCPCS A9153Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified
HCPCS A9581Injection, gadoxetate disodium, 1 ml
HCPCS A9582Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
HCPCS A9583Injection, gadofosveset trisodium, 1 ml
HCPCS A9604Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
HCPCS C1178INJECTION, BUSULFAN, PER 6 MG
HCPCS C8950INTRAVENOUS INFUSION FOR THERAPY/DIAGNOSIS; UP TO 1 HOUR
HCPCS C8951INTRAVENOUS INFUSION FOR THERAPY/DIAGNOSIS; EACH ADDITIONAL HOUR (LIST SEPARATELY IN ADDITION TO C8950)
HCPCS C8952THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC INJECTION; INTRAVENOUS PUSH OF EACH NEW SUBSTANCE/DRUG
HCPCS C8953CHEMOTHERAPY ADMINISTRATION, INTRAVENOUS; PUSH TECHNIQUE
HCPCS C8954CHEMOTHERAPY ADMINISTRATION, INTRAVENOUS; INFUSION TECHNIQUE, UP TO ONE HOUR
HCPCS C8955CHEMOTHERAPY ADMINISTRATION, INTRAVENOUS; INFUSION TECHNIQUE, EACH ADDITIONAL HOUR (LIST SEPARATELY IN ADDITION TO C8954)
HCPCS C8957Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
HCPCS C9000INJECTION, SODIUM CHROMATE CR51, PER 0.25 MCI
HCPCS C9003PALIVIZUMAB-RSV-IGM, PER 50 MG
HCPCS C9007BACLOFEN INTRATHECAL SCREENING KIT (1 AMP)
HCPCS C9008BACLOFEN INTRATHECAL REFILL KIT, PER 500 MCG
HCPCS C9009BACLOFEN INTRATHECAL REFILL KIT, PER 2000 MCG
HCPCS C9105INJECTION, HEPATITIS B IMMUNE GLOBULIN, PER 1 ML
HCPCS C9109INJECTION, TIROFIBAN HYDROCHLORIDE, 6.25 MG
HCPCS C9112INJECTION, PERFLUTREN LIPID MICROSPHERE, PER 2 ML VIAL
HCPCS C9113Injection, pantoprazole sodium, per vial
HCPCS C9121Injection, argatroban, per 5 mg
HCPCS C9124INJECTION, DAPTOMYCIN, PER 1 MG
HCPCS C9125INJECTION, RISPERIDONE, PER 12.5 MG
HCPCS C9126INJECTION, NATALIZUMAB, PER 5 MG
HCPCS C9127INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, PER 1 MG
HCPCS C9128INJECTION, PEGAPTANIB SODIUM, PER 0.3 MG
HCPCS C9129INJECTION, CLOFARABINE, PER 1 MG
HCPCS C9202INJECTION, SUSPENSION OF MICROSPHERES OF HUMAN SERUM ALBUMIN WITH OCTAFLUOROPROPANE, PER 3 ML
HCPCS C9203INJECTION, PERFLEXANE LIPID MICROSPHERES, PER 10 ML VIAL
HCPCS C9205INJECTION, OXALIPLATIN, PER 5 MG
HCPCS C9207INJECTION, BORTEZOMIB, PER 3.5 MG
HCPCS C9208INJECTION, AGALSIDASE BETA, PER 1 MG
HCPCS C9209INJECTION, LARONIDASE, PER 2.9 MG
HCPCS C9210INJECTION, PALONOSETRON HYDROCHLORIDE, PER 250 MCG
HCPCS C9211INJECTION, ALEFACEPT, FOR INTRAVENOUS USE, PER 7.5 MG
HCPCS C9212INJECTION, ALEFACEPT, FOR INTRAMUSCULAR USE, PER 7.5 MG
HCPCS C9213INJECTION, PEMETREXED, PER 10 MG
HCPCS C9214INJECTION, BEVACIZUMAB, PER 10 MG
HCPCS C9215INJECTION, CETUXIMAB, PER 10 MG
HCPCS C9216INJECTION, ABARELIX FOR INJECTABLE SUSPENSION, PER 10 MG
HCPCS C9217INJECTION, OMALIZUMAB, PER 5 MG
HCPCS C9218INJECTION, AZACITIDINE, PER 1 MG
HCPCS C9219MYCOPHENOLIC ACID, ORAL, PER 180 MG
HCPCS C9220SODIUM HYALURONATE PER 30 MG DOSE, FOR INTRA-ARTICULAR INJECTION
HCPCS C9223INJECTION, ADENOSINE FOR THERAPEUTIC OR DIAGNOSTIC USE, 6 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS, INSTEAD USE A9270)
HCPCS C9224INJECTION, GALSULFASE, PER 5 MG
HCPCS C9225INJECTION, FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT, PER 0.59 MG
HCPCS C9226INJECTION, ZICONOTIDE FOR INTRATHECAL INFUSION, PER 5 MCG
HCPCS C9232INJECTION, IDURSULFASE, 1 MG
HCPCS C9233INJECTION, RANIBIZUMAB, 0.5 MG
HCPCS C9234INJECTION, ALGLUCOSIDASE ALFA, 10 MG
HCPCS C9235INJECTION, PANITUMUMAB, 10 MG
HCPCS C9236INJECTION, ECULIZUMAB, 10 MG
HCPCS C9237INJECTION, LANREOTIDE ACETATE, 1 MG
HCPCS C9238INJECTION, LEVETIRACETAM, 10 MG
HCPCS C9239INJECTION, TEMSIROLIMUS, 1 MG
HCPCS C9240INJECTION, IXABEPILONE, 1 MG
HCPCS C9241INJECTION, DORIPENEM, 10 MG
HCPCS C9242INJECTION, FOSAPREPITANT, 1 MG
HCPCS C9243INJECTION, BENDAMUSTINE HCL, 1 MG
HCPCS C9244INJECTION, REGADENOSON, 0.4 MG
HCPCS C9245INJECTION, ROMIPLOSTIM, 10 MCG
HCPCS C9246INJECTION, GADOXETATE DISODIUM, PER ML
HCPCS C9247IOBENGUANE, I-123, DIAGNOSTIC, PER STUDY DOSE, UP TO 10 MILLICURIES
HCPCS C9248Injection, clevidipine butyrate, 1 mg
HCPCS C9249INJECTION, CERTOLIZUMAB PEGOL, 1 MG
HCPCS C9251INJECTION, C1 ESTERASE INHIBITOR (HUMAN), 10 UNITS
HCPCS C9252INJECTION, PLERIXAFOR, 1 MG
HCPCS C9253INJECTION, TEMOZOLOMIDE, 1 MG
HCPCS C9254Injection, lacosamide, 1 mg
HCPCS C9255Injection, paliperidone palmitate, 1 mg
HCPCS C9256Injection, dexamethasone intravitreal implant, 0.1 mg
HCPCS C9257Injection, bevacizumab, 0.25 mg
HCPCS C9258Injection, telavancin, 10 mg
HCPCS C9259Injection, pralatrexate, 1 mg
HCPCS C9260Injection, ofatumumab, 10 mg
HCPCS C9261Injection, ustekinumab, 1 mg
HCPCS C9262Fludarabine phosphate, oral, 1 mg
HCPCS C9263Injection, ecallantide, 1 mg
HCPCS C9264Injection, tocilizumab, 1 mg
HCPCS C9265Injection, romidepsin, 1 mg
HCPCS C9266Injection, collagenase clostridium histolyticum, 0.1 mg
HCPCS C9267Injection, von willebrand factor complex (human), wilate, per 100 iu vwf: rco
HCPCS C9268Capsaicin, patch, 10cm2
HCPCS C9269Injection, c-1 esterase inhibitor (human), berinert, 10 units
HCPCS C9270Injection, immune globulin (gammaplex), intravenous, non-lyophilized (e.g. liquid), 500 mg
HCPCS C9271Injection, velaglucerase alfa, 100 units
HCPCS C9272Injection, denosumab, 1 mg
HCPCS C9273Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
HCPCS C9274Crotalidae polyvalent immune fab (ovine), 1 vial
HCPCS C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
HCPCS C9276Injection, cabazitaxel, 1 mg
HCPCS C9277Injection, alglucosidase alfa (lumizyme), 1 mg
HCPCS C9278Injection, incobotulinumtoxin a, 1 unit
HCPCS C9279Injection, ibuprofen, 100 mg
HCPCS C9280Injection, eribulin mesylate, 1 mg
HCPCS C9281Injection, pegloticase, 1 mg
HCPCS C9282Injection, ceftaroline fosamil, 10 mg
HCPCS C9283Injection, acetaminophen, 10 mg
HCPCS C9284Injection, ipilimumab, 1 mg
HCPCS C9285Lidocaine 70 mg/tetracaine 70 mg, per patch
HCPCS C9286Injection, belatacept, 1 mg
HCPCS C9287Injection, brentuximab vedotin, 1 mg
HCPCS C9288Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial
HCPCS C9289Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i.u.)
HCPCS C9290Injection, bupivacaine liposome, 1 mg
HCPCS C9291Injection, aflibercept, 2 mg vial
HCPCS C9292Injection, pertuzumab, 10 mg
HCPCS C9293Injection, glucarpidase, 10 units
HCPCS C9294Injection, taliglucerase alfa, 10 units
HCPCS C9295Injection, carfilzomib, 1 mg
HCPCS C9296Injection, ziv-aflibercept, 1 mg
HCPCS C9399Unclassified drugs or biologicals
HCPCS C9410INJECTION, DEXRAZOXANE HYDROCHLORIDE, BRAND NAME, PER 250 MG
HCPCS C9411INJECTION, PAMIDRONATE DISODIUM, BRAND NAME, PER 30 MG
HCPCS C9412GANCICLOVIR, 4.5 MG, LONG-ACTING IMPLANT, BRAND NAME
HCPCS C9413SODIUM HYALURONATE, PER 20 TO 25 MG DOSE FOR INTRA-ARTICULAR INJECTION, BRAND NAME
HCPCS C9414ETOPOSIDE, ORAL, BRAND NAME, 50 MG
HCPCS C9415DOXORUBICIN HCL, BRAND NAME, 10 MG
HCPCS C9417BLEOMYCIN SULFATE, BRAND NAME, 15 UNITS
HCPCS C9418CISPLATIN, POWDER OR S0LUTION, BRAND NAME, PER 10 MG
HCPCS C9419INJECTION, CLADRIBINE, BRAND NAME, PER 1 MG
HCPCS C9420CYCLOPHOSPHAMIDE, BRAND NAME, 100 MG
HCPCS C9421CYCLOPHOSPHAMIDE, LYOPHILIZED, BRAND NAME, 100 MG
HCPCS C9422CYTARABINE, BRAND NAME, 100 MG
HCPCS C9423DACARBAZINE, BRAND NAME, 100 MG
HCPCS C9424DAUNORUBICIN, BRAND NAME, 10 MG
HCPCS C9425ETOPOSIDE, BRAND NAME, 10 MG
HCPCS C9426FLOXURIDINE, BRAND NAME, 500 MG
HCPCS C9427IFOSFAMIDE, BRAND NAME, 1 GM
HCPCS C9428MESNA, BRAND NAME, 200 MG
HCPCS C9429IDARUBICIN HYDROCHLORIDE, BRAND NAME, 5 MG
HCPCS C9430LEUPROLIDE ACETATE, BRAND NAME, PER 1 MG
HCPCS C9431PACLITAXEL, BRAND NAME, 30 MG
HCPCS C9432MITOMYCIN, BRAND NAME, 5 MG
HCPCS C9433THIOTEPA, BRAND NAME, 15 MG
HCPCS C9435INJECTION, GONADORELIN HYDROCHLORIDE, BRAND NAME, PER 100 MCG
HCPCS C9436AZATHIOPRINE, PARENTERAL, BRAND NAME, PER 100 MG
HCPCS C9437CARMUSTINE, BRAND NAME, 100 MG
HCPCS C9438CYCLOSPORINE, ORAL, BRAND NAME, 100 MG
HCPCS C9439DIETHYLSTILBESTROL DIPHOSPHATE, BRAND NAME, 250 MG
HCPCS C9440VINORELBINE TARTRATE, BRAND NAME, PER 10 MG
HCPCS G0292ADMINISTRATION(S) OF EXPERIMENTAL DRUG(S) ONLY IN A MEDICARE QUALIFYING
HCPCS G0333Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
HCPCS G0351THERAPEUTIC OR DIAGNOSTIC INJECTION (SPECIFY SUBSTANCE OR DRUG); SUBCUTANEOUS OR INTRAMUSCULAR
HCPCS G0369PHARMACY SUPPLY FEE FOR INITIAL IMMUNOSUPPRESSIVE DRUG(S) FIRST MONTH FOLLOWING
HCPCS G0370PHARMACY SUPPLY FEE FOR ORAL ANTI-CANCER, ORAL ANTI-EMETIC OR IMMUNOSUPPRESSIVE
HCPCS G0371PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); PER 30 DAYS
HCPCS G0374PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); PER 90 DAYS
HCPCS G0377ADMINISTRATION OF VACCINE FOR PART D DRUG
HCPCS G0429Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)
HCPCS G3001Administration and supply of tositumomab, 450 mg
HCPCS G9147Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration
HCPCS J0120Injection, tetracycline, up to 250 mg
HCPCS J0128Injection, abarelix, 10 mg
HCPCS J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J0130Injection abciximab, 10 mg
HCPCS J0131Injection, acetaminophen, not otherwise specified,10 mg
HCPCS J0132Injection, acetylcysteine, 100 mg
HCPCS J0133Injection, acyclovir, 5 mg
HCPCS J0135Injection, adalimumab, 20 mg
HCPCS J0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)
HCPCS J0152Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)
HCPCS J0170Injection, adrenalin, epinephrine, up to 1 ml ampule
HCPCS J0171Injection, adrenalin, epinephrine, 0.1 mg
HCPCS J0178Injection, aflibercept, 1 mg
HCPCS J0180Injection, agalsidase beta, 1 mg
HCPCS J0190Injection, biperiden lactate, per 5 mg
HCPCS J0200Injection, alatrofloxacin mesylate, 100 mg
HCPCS J0205Injection, alglucerase, per 10 units
HCPCS J0207Injection, amifostine, 500 mg
HCPCS J0210Injection, methyldopate hcl, up to 250 mg
HCPCS J0215Injection, alefacept, 0.5 mg
HCPCS J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified
HCPCS J0221Injection, alglucosidase alfa, (lumizyme), 10 mg
HCPCS J0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
HCPCS J0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
HCPCS J0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J0278Injection, amikacin sulfate, 100 mg
HCPCS J0280Injection, aminophyllin, up to 250 mg
HCPCS J0282Injection, amiodarone hydrochloride, 30 mg
HCPCS J0285Injection, amphotericin b, 50 mg
HCPCS J0287Injection, amphotericin b lipid complex, 10 mg
HCPCS J0288Injection, amphotericin b cholesteryl sulfate complex, 10 mg
HCPCS J0289Injection, amphotericin b liposome, 10 mg
HCPCS J0290Injection, ampicillin sodium, 500 mg
HCPCS J0295Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
HCPCS J0300Injection, amobarbital, up to 125 mg
HCPCS J0330Injection, succinylcholine chloride, up to 20 mg
HCPCS J0348Injection, anidulafungin, 1 mg
HCPCS J0350Injection, anistreplase, per 30 units
HCPCS J0360Injection, hydralazine hcl, up to 20 mg
HCPCS J0364Injection, apomorphine hydrochloride, 1 mg
HCPCS J0365Injection, aprotonin, 10,000 kiu
HCPCS J0380Injection, metaraminol bitartrate, per 10 mg
HCPCS J0390Injection, chloroquine hydrochloride, up to 250 mg
HCPCS J0395Injection, arbutamine hcl, 1 mg
HCPCS J0400Injection, aripiprazole, intramuscular, 0.25 mg
HCPCS J0456Injection, azithromycin, 500 mg
HCPCS J0460INJECTION, ATROPINE SULFATE, UP TO 0.3 MG
HCPCS J0461Injection, atropine sulfate, 0.01 mg
HCPCS J0470Injection, dimercaprol, per 100 mg
HCPCS J0475Injection, baclofen, 10 mg
HCPCS J0476Injection, baclofen, 50 mcg for intrathecal trial
HCPCS J0480Injection, basiliximab, 20 mg
HCPCS J0485Injection, belatacept, 1 mg
HCPCS J0490Injection, belimumab, 10 mg
HCPCS J0500Injection, dicyclomine hcl, up to 20 mg
HCPCS J0515Injection, benztropine mesylate, per 1 mg
HCPCS J0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
HCPCS J0530INJECTION, PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE, UP TO 600,000 UNITS
HCPCS J0540INJECTION, PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE, UP TO 1,200,000 UNITS
HCPCS J0550INJECTION, PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE, UP TO 2,400,000 UNITS
HCPCS J0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
HCPCS J0559Injection, penicillin g benzathine and penicillin g procaine, 2500 units
HCPCS J0560Injection, penicillin g benzathine, up to 600,000 units
HCPCS J0561Injection, penicillin g benzathine, 100,000 units
HCPCS J0570Buprenorphine implant, 74.2 mg
HCPCS J0580Injection, penicillin g benzathine, up to 2,400,000 units
HCPCS J0583Injection, bivalirudin, 1 mg
HCPCS J0585Injection, onabotulinumtoxina, 1 unit
HCPCS J0586Injection, abobotulinumtoxina, 5 units
HCPCS J0587Injection, rimabotulinumtoxinb, 100 units
HCPCS J0588Injection, incobotulinumtoxin a, 1 unit
HCPCS J0592Injection, buprenorphine hydrochloride, 0.1 mg
HCPCS J0594injection, busulfan, 1 mg
HCPCS J0595Injection, butorphanol tartrate, 1 mg
HCPCS J0597Injection, c-1 esterase inhibitor (human), berinert, 10 units
HCPCS J0598Injection, c-1 esterase inhibitor (human), cinryze, 10 units
HCPCS J0600Injection, edetate calcium disodium, up to 1000 mg
HCPCS J0610Injection, calcium gluconate (fresenius kabi), per 10 ml
HCPCS J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
HCPCS J0630Injection, calcitonin salmon, up to 400 units
HCPCS J0636Injection, calcitriol, 0.1 mcg
HCPCS J0637Injection, caspofungin acetate, 5 mg
HCPCS J0638Injection, canakinumab, 1 mg
HCPCS J0640Injection, leucovorin calcium, per 50 mg
HCPCS J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg
HCPCS J0670Injection, mepivacaine hydrochloride, per 10 ml
HCPCS J0690Injection, cefazolin sodium, 500 mg
HCPCS J0692Injection, cefepime hydrochloride, 500 mg
HCPCS J0694Injection, cefoxitin sodium, 1 gm
HCPCS J0696Injection, ceftriaxone sodium, per 250 mg
HCPCS J0697Injection, sterile cefuroxime sodium, per 750 mg
HCPCS J0698Injection, cefotaxime sodium, per gm
HCPCS J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
HCPCS J0704Injection, betamethasone sodium phosphate, per 4 mg
HCPCS J0706Injection, caffeine citrate, 5 mg
HCPCS J0710Injection, cephapirin sodium, up to 1 gm
HCPCS J0712Injection, ceftaroline fosamil, 10 mg
HCPCS J0713Injection, ceftazidime, per 500 mg
HCPCS J0715Injection, ceftizoxime sodium, per 500 mg
HCPCS J0716Injection, centruroides immune f(ab)2, up to 120 milligrams
HCPCS J0718Injection, certolizumab pegol, 1 mg
HCPCS J0720Injection, chloramphenicol sodium succinate, up to 1 gm
HCPCS J0725Injection, chorionic gonadotropin, per 1,000 usp units
HCPCS J0735Injection, clonidine hydrochloride, 1 mg
HCPCS J0740Injection, cidofovir, 375 mg
HCPCS J0743Injection, cilastatin sodium; imipenem, per 250 mg
HCPCS J0744Injection, ciprofloxacin for intravenous infusion, 200 mg
HCPCS J0745Injection, codeine phosphate, per 30 mg
HCPCS J0760Injection, colchicine, per 1 mg
HCPCS J0770Injection, colistimethate sodium, up to 150 mg
HCPCS J0775Injection, collagenase, clostridium histolyticum, 0.01 mg
HCPCS J0780Injection, prochlorperazine, up to 10 mg
HCPCS J0795Injection, corticorelin ovine triflutate, 1 microgram
HCPCS J0800Injection, corticotropin, up to 40 units
HCPCS J0833Injection, cosyntropin, not otherwise specified, 0.25 mg
HCPCS J0834Injection, cosyntropin, 0.25 mg
HCPCS J0835INJECTION, COSYNTROPIN, PER 0.25 MG
HCPCS J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
HCPCS J0878Injection, daptomycin, 1 mg
HCPCS J0880INJECTION, DARBEPOETIN ALFA, 5 MCG
HCPCS J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)
HCPCS J0882Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
HCPCS J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
HCPCS J0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)
HCPCS J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)
HCPCS J0894Injection, decitabine, 1 mg
HCPCS J0895Injection, deferoxamine mesylate, 500 mg
HCPCS J0897Injection, denosumab, 1 mg
HCPCS J0900Injection, testosterone enanthate and estradiol valerate, up to 1 cc
HCPCS J0945Injection, brompheniramine maleate, per 10 mg
HCPCS J0970Injection, estradiol valerate, up to 40 mg
HCPCS J1000Injection, depo-estradiol cypionate, up to 5 mg
HCPCS J1020Injection, methylprednisolone acetate, 20 mg
HCPCS J1030Injection, methylprednisolone acetate, 40 mg
HCPCS J1040Injection, methylprednisolone acetate, 80 mg
HCPCS J1050Injection, medroxyprogesterone acetate, 1 mg
HCPCS J1051Injection, medroxyprogesterone acetate, 50 mg
HCPCS J1055Injection, medroxyprogesterone acetate for contraceptive use, 150 mg
HCPCS J1056Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg
HCPCS J1060Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
HCPCS J1070Injection, testosterone cypionate, up to 100 mg
HCPCS J1080Injection, testosterone cypionate, 1 cc, 200 mg
HCPCS J1094Injection, dexamethasone acetate, 1 mg
HCPCS J1100Injection, dexamethasone sodium phosphate, 1 mg
HCPCS J1110Injection, dihydroergotamine mesylate, per 1 mg
HCPCS J1120Injection, acetazolamide sodium, up to 500 mg
HCPCS J1160Injection, digoxin, up to 0.5 mg
HCPCS J1162Injection, digoxin immune fab (ovine), per vial
HCPCS J1165Injection, phenytoin sodium, per 50 mg
HCPCS J1170Injection, hydromorphone, up to 4 mg
HCPCS J1180Injection, dyphylline, up to 500 mg
HCPCS J1190Injection, dexrazoxane hydrochloride, per 250 mg
HCPCS J1200Injection, diphenhydramine hcl, up to 50 mg
HCPCS J1205Injection, chlorothiazide sodium, per 500 mg
HCPCS J1212Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
HCPCS J1230Injection, methadone hcl, up to 10 mg
HCPCS J1240Injection, dimenhydrinate, up to 50 mg
HCPCS J1245Injection, dipyridamole, per 10 mg
HCPCS J1250Injection, dobutamine hydrochloride, per 250 mg
HCPCS J1260Injection, dolasetron mesylate, 10 mg
HCPCS J1265Injection, dopamine hcl, 40 mg
HCPCS J1267Injection, doripenem, 10 mg
HCPCS J1270Injection, doxercalciferol, 1 mcg
HCPCS J1290Injection, ecallantide, 1 mg
HCPCS J1300Injection, eculizumab, 10 mg
HCPCS J1320Injection, amitriptyline hcl, up to 20 mg
HCPCS J1324Injection, enfuvirtide, 1 mg
HCPCS J1325Injection, epoprostenol, 0.5 mg
HCPCS J1327Injection, eptifibatide, 5 mg
HCPCS J1330Injection, ergonovine maleate, up to 0.2 mg
HCPCS J1335Injection, ertapenem sodium, 500 mg
HCPCS J1364Injection, erythromycin lactobionate, per 500 mg
HCPCS J1380Injection, estradiol valerate, up to 10 mg
HCPCS J1390Injection, estradiol valerate, up to 20 mg
HCPCS J1410Injection, estrogen conjugated, per 25 mg
HCPCS J1430Injection, ethanolamine oleate, 100 mg
HCPCS J1435Injection, estrone, per 1 mg
HCPCS J1436Injection, etidronate disodium, per 300 mg
HCPCS J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J1440Fecal microbiota, live - jslm, 1 ml
HCPCS J1441Injection, filgrastim (g-csf), 480 mcg
HCPCS J1450Injection fluconazole, 200 mg
HCPCS J1451Injection, fomepizole, 15 mg
HCPCS J1452Injection, fomivirsen sodium, intraocular, 1.65 mg
HCPCS J1453Injection, fosaprepitant, 1 mg
HCPCS J1455Injection, foscarnet sodium, per 1000 mg
HCPCS J1457Injection, gallium nitrate, 1 mg
HCPCS J1458Injection, galsulfase, 1 mg
HCPCS J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
HCPCS J1460Injection, gamma globulin, intramuscular, 1 cc
HCPCS J1470Injection, gamma globulin, intramuscular, 2 cc
HCPCS J1480Injection, gamma globulin, intramuscular, 3 cc
HCPCS J1490Injection, gamma globulin, intramuscular, 4 cc
HCPCS J1500Injection, gamma globulin, intramuscular, 5 cc
HCPCS J1510Injection, gamma globulin, intramuscular, 6 cc
HCPCS J1520Injection, gamma globulin, intramuscular, 7 cc
HCPCS J1530Injection, gamma globulin, intramuscular, 8 cc
HCPCS J1540Injection, gamma globulin, intramuscular, 9 cc
HCPCS J1550Injection, gamma globulin, intramuscular, 10 cc
HCPCS J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
HCPCS J1559Injection, immune globulin (hizentra), 100 mg
HCPCS J1560Injection, gamma globulin, intramuscular, over 10 cc
HCPCS J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
HCPCS J1562Injection, immune globulin (vivaglobin), 100 mg
HCPCS J1563INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, 1G
HCPCS J1564INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, 10 MG
HCPCS J1565INJECTION, RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN, INTRAVENOUS, 50 MG
HCPCS J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
HCPCS J1567INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
HCPCS J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
HCPCS J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
HCPCS J1570Injection, ganciclovir sodium, 500 mg
HCPCS J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
HCPCS J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
HCPCS J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
HCPCS J1580Injection, garamycin, gentamicin, up to 80 mg
HCPCS J1590Injection, gatifloxacin, 10 mg
HCPCS J1595Injection, glatiramer acetate, 20 mg
HCPCS J1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
HCPCS J1600Injection, gold sodium thiomalate, up to 50 mg
HCPCS J1610Injection, glucagon hydrochloride, per 1 mg
HCPCS J1620Injection, gonadorelin hydrochloride, per 100 mcg
HCPCS J1626Injection, granisetron hydrochloride, 100 mcg
HCPCS J1630Injection, haloperidol, up to 5 mg
HCPCS J1631Injection, haloperidol decanoate, per 50 mg
HCPCS J1640Injection, hemin, 1 mg
HCPCS J1642Injection, heparin sodium, (heparin lock flush), per 10 units
HCPCS J1644Injection, heparin sodium, per 1000 units
HCPCS J1645Injection, dalteparin sodium, per 2500 iu
HCPCS J1650Injection, enoxaparin sodium, 10 mg
HCPCS J1652Injection, fondaparinux sodium, 0.5 mg
HCPCS J1655Injection, tinzaparin sodium, 1000 iu
HCPCS J1670Injection, tetanus immune globulin, human, up to 250 units
HCPCS J1675Injection, histrelin acetate, 10 micrograms
HCPCS J1680Injection, human fibrinogen concentrate, 100 mg
HCPCS J1700Injection, hydrocortisone acetate, up to 25 mg
HCPCS J1710Injection, hydrocortisone sodium phosphate, up to 50 mg
HCPCS J1720Injection, hydrocortisone sodium succinate, up to 100 mg
HCPCS J1725Injection, hydroxyprogesterone caproate, 1 mg
HCPCS J1730Injection, diazoxide, up to 300 mg
HCPCS J1740Injection, ibandronate sodium, 1 mg
HCPCS J1741Injection, ibuprofen, 100 mg
HCPCS J1742Injection, ibutilide fumarate, 1 mg
HCPCS J1743Injection, idursulfase, 1 mg
HCPCS J1744Injection, icatibant, 1 mg
HCPCS J1745Injection, infliximab, excludes biosimilar, 10 mg
HCPCS J1750Injection, iron dextran, 50 mg
HCPCS J1751INJECTION, IRON DEXTRAN 165, 50 MG
HCPCS J1752INJECTION, IRON DEXTRAN 267, 50 MG
HCPCS J1756Injection, iron sucrose, 1 mg
HCPCS J1785Injection, imiglucerase, per unit
HCPCS J1786Injection, imiglucerase, 10 units
HCPCS J1790Injection, droperidol, up to 5 mg
HCPCS J1800Injection, propranolol hcl, up to 1 mg
HCPCS J1810Injection, droperidol and fentanyl citrate, up to 2 ml ampule
HCPCS J1815Injection, insulin, per 5 units
HCPCS J1817Insulin for administration through dme (i.e., insulin pump) per 50 units
HCPCS J1825Injection, interferon beta-1a, 33 mcg
HCPCS J1826Injection, interferon beta-1a, 30 mcg
HCPCS J1830Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J1835Injection, itraconazole, 50 mg
HCPCS J1840Injection, kanamycin sulfate, up to 500 mg
HCPCS J1850Injection, kanamycin sulfate, up to 75 mg
HCPCS J1885Injection, ketorolac tromethamine, per 15 mg
HCPCS J1890Injection, cephalothin sodium, up to 1 gram
HCPCS J1930Injection, lanreotide, 1 mg
HCPCS J1931Injection, laronidase, 0.1 mg
HCPCS J1940Injection, furosemide, up to 20 mg
HCPCS J1945Injection, lepirudin, 50 mg
HCPCS J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
HCPCS J1953Injection, levetiracetam, 10 mg
HCPCS J1955Injection, levocarnitine, per 1 gm
HCPCS J1956Injection, levofloxacin, 250 mg
HCPCS J1960Injection, levorphanol tartrate, up to 2 mg
HCPCS J1980Injection, hyoscyamine sulfate, up to 0.25 mg
HCPCS J1990Injection, chlordiazepoxide hcl, up to 100 mg
HCPCS J2001Injection, lidocaine hcl for intravenous infusion, 10 mg
HCPCS J2010Injection, lincomycin hcl, up to 300 mg
HCPCS J2020Injection, linezolid, 200 mg
HCPCS J2060Injection, lorazepam, 2 mg
HCPCS J2150Injection, mannitol, 25% in 50 ml
HCPCS J2170Injection, mecasermin, 1 mg
HCPCS J2175Injection, meperidine hydrochloride, per 100 mg
HCPCS J2180Injection, meperidine and promethazine hcl, up to 50 mg
HCPCS J2185Injection, meropenem, 100 mg
HCPCS J2210Injection, methylergonovine maleate, up to 0.2 mg
HCPCS J2212Injection, methylnaltrexone, 0.1 mg
HCPCS J2248Injection, micafungin sodium, 1 mg
HCPCS J2250Injection, midazolam hydrochloride, per 1 mg
HCPCS J2260Injection, milrinone lactate, 5 mg
HCPCS J2265Injection, minocycline hydrochloride, 1 mg
HCPCS J2270Injection, morphine sulfate, up to 10 mg
HCPCS J2271Injection, morphine sulfate, 100mg
HCPCS J2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
HCPCS J2278Injection, ziconotide, 1 microgram
HCPCS J2280Injection, moxifloxacin, 100 mg
HCPCS J2300Injection, nalbuphine hydrochloride, per 10 mg
HCPCS J2310Injection, naloxone hydrochloride, per 1 mg
HCPCS J2315Injection, naltrexone, depot form, 1 mg
HCPCS J2320Injection, nandrolone decanoate, up to 50 mg
HCPCS J2321Injection, nandrolone decanoate, up to 100 mg
HCPCS J2322Injection, nandrolone decanoate, up to 200 mg
HCPCS J2323Injection, natalizumab, 1 mg
HCPCS J2324INJECTION, NESIRITIDE, 0.25 MG
HCPCS J2325Injection, nesiritide, 0.1 mg
HCPCS J2353Injection, octreotide, depot form for intramuscular injection, 1 mg
HCPCS J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
HCPCS J2355Injection, oprelvekin, 5 mg
HCPCS J2357Injection, omalizumab, 5 mg
HCPCS J2358Injection, olanzapine, long-acting, 1 mg
HCPCS J2360Injection, orphenadrine citrate, up to 60 mg
HCPCS J2370Injection, phenylephrine hcl, up to 1 ml
HCPCS J2400Injection, chloroprocaine hydrochloride, per 30 ml
HCPCS J2405Injection, ondansetron hydrochloride, per 1 mg
HCPCS J2410Injection, oxymorphone hcl, up to 1 mg
HCPCS J2425Injection, palifermin, 50 micrograms
HCPCS J2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
HCPCS J2430Injection, pamidronate disodium, per 30 mg
HCPCS J2440Injection, papaverine hcl, up to 60 mg
HCPCS J2460Injection, oxytetracycline hcl, up to 50 mg
HCPCS J2469Injection, palonosetron hcl, 25 mcg
HCPCS J2501Injection, paricalcitol, 1 mcg
HCPCS J2503Injection, pegaptanib sodium, 0.3 mg
HCPCS J2504Injection, pegademase bovine, 25 iu
HCPCS J2505Injection, pegfilgrastim, 6 mg
HCPCS J2507Injection, pegloticase, 1 mg
HCPCS J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
HCPCS J2513Injection, pentastarch, 10% solution, 100 ml
HCPCS J2515Injection, pentobarbital sodium, per 50 mg
HCPCS J2540Injection, penicillin g potassium, up to 600,000 units
HCPCS J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
HCPCS J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
HCPCS J2550Injection, promethazine hcl, up to 50 mg
HCPCS J2560Injection, phenobarbital sodium, up to 120 mg
HCPCS J2562Injection, plerixafor, 1 mg
HCPCS J2590Injection, oxytocin, up to 10 units
HCPCS J2597Injection, desmopressin acetate, per 1 mcg
HCPCS J2650Injection, prednisolone acetate, up to 1 ml
HCPCS J2670Injection, tolazoline hcl, up to 25 mg
HCPCS J2675Injection, progesterone, per 50 mg
HCPCS J2680Injection, fluphenazine decanoate, up to 25 mg
HCPCS J2690Injection, procainamide hcl, up to 1 gm
HCPCS J2700Injection, oxacillin sodium, up to 250 mg
HCPCS J2710Injection, neostigmine methylsulfate, up to 0.5 mg
HCPCS J2720Injection, protamine sulfate, per 10 mg
HCPCS J2724Injection, protein c concentrate, intravenous, human, 10 iu
HCPCS J2725Injection, protirelin, per 250 mcg
HCPCS J2730Injection, pralidoxime chloride, up to 1 gm
HCPCS J2760Injection, phentolamine mesylate, up to 5 mg
HCPCS J2765Injection, metoclopramide hcl, up to 10 mg
HCPCS J2770Injection, quinupristin/dalfopristin, 500 mg (150/350)
HCPCS J2778Injection, ranibizumab, 0.1 mg
HCPCS J2780Injection, ranitidine hydrochloride, 25 mg
HCPCS J2783Injection, rasburicase, 0.5 mg
HCPCS J2785Injection, regadenoson, 0.1 mg
HCPCS J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
HCPCS J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
HCPCS J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
HCPCS J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
HCPCS J2793Injection, rilonacept, 1 mg
HCPCS J2794Injection, risperidone (risperdal consta), 0.5 mg
HCPCS J2795Injection, ropivacaine hydrochloride, 1 mg
HCPCS J2796Injection, romiplostim, 10 micrograms
HCPCS J2800Injection, methocarbamol, up to 10 ml
HCPCS J2805Injection, sincalide, 5 micrograms
HCPCS J2810Injection, theophylline, per 40 mg
HCPCS J2820Injection, sargramostim (gm-csf), 50 mcg
HCPCS J2850Injection, secretin, synthetic, human, 1 microgram
HCPCS J2910Injection, aurothioglucose, up to 50 mg
HCPCS J2912INJECTION, SODIUM CHLORIDE, 0.9%, PER 2 ML
HCPCS J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
HCPCS J2920Injection, methylprednisolone sodium succinate, up to 40 mg
HCPCS J2930Injection, methylprednisolone sodium succinate, up to 125 mg
HCPCS J2940Injection, somatrem, 1 mg
HCPCS J2941Injection, somatropin, 1 mg
HCPCS J2950Injection, promazine hcl, up to 25 mg
HCPCS J2993Injection, reteplase, 18.1 mg
HCPCS J2995Injection, streptokinase, per 250,000 iu
HCPCS J2997Injection, alteplase recombinant, 1 mg
HCPCS J3000Injection, streptomycin, up to 1 gm
HCPCS J3010Injection, fentanyl citrate, 0.1 mg
HCPCS J3030Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
HCPCS J3070Injection, pentazocine, 30 mg
HCPCS J3095Injection, telavancin, 10 mg
HCPCS J3100INJECTION, TENECTEPLASE, 50MG
HCPCS J3101Injection, tenecteplase, 1 mg
HCPCS J3105Injection, terbutaline sulfate, up to 1 mg
HCPCS J3110Injection, teriparatide, 10 mcg
HCPCS J3120Injection, testosterone enanthate, up to 100 mg
HCPCS J3130Injection, testosterone enanthate, up to 200 mg
HCPCS J3140Injection, testosterone suspension, up to 50 mg
HCPCS J3150Injection, testosterone propionate, up to 100 mg
HCPCS J3230Injection, chlorpromazine hcl, up to 50 mg
HCPCS J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
HCPCS J3243Injection, tigecycline, 1 mg
HCPCS J3245Injection, tildrakizumab, 1 mg
HCPCS J3246Injection, tirofiban hcl, 0.25 mg
HCPCS J3250Injection, trimethobenzamide hcl, up to 200 mg
HCPCS J3260Injection, tobramycin sulfate, up to 80 mg
HCPCS J3262Injection, tocilizumab, 1 mg
HCPCS J3265Injection, torsemide, 10 mg/ml
HCPCS J3280Injection, thiethylperazine maleate, up to 10 mg
HCPCS J3285Injection, treprostinil, 1 mg
HCPCS J3300Injection, triamcinolone acetonide, preservative free, 1 mg
HCPCS J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg
HCPCS J3302Injection, triamcinolone diacetate, per 5 mg
HCPCS J3303Injection, triamcinolone hexacetonide, per 5 mg
HCPCS J3305Injection, trimetrexate glucuronate, per 25 mg
HCPCS J3310Injection, perphenazine, up to 5 mg
HCPCS J3315Injection, triptorelin pamoate, 3.75 mg
HCPCS J3320Injection, spectinomycin dihydrochloride, up to 2 gm
HCPCS J3350Injection, urea, up to 40 gm
HCPCS J3355Injection, urofollitropin, 75 iu
HCPCS J3357Ustekinumab, for subcutaneous injection, 1 mg
HCPCS J3360Injection, diazepam, up to 5 mg
HCPCS J3364Injection, urokinase, 5000 iu vial
HCPCS J3365Injection, iv, urokinase, 250,000 i.u. vial
HCPCS J3370Injection, vancomycin hcl, 500 mg
HCPCS J3385Injection, velaglucerase alfa, 100 units
HCPCS J3395INJECTION, VERTEPORFIN, 15MG
HCPCS J3396Injection, verteporfin, 0.1 mg
HCPCS J3400Injection, triflupromazine hcl, up to 20 mg
HCPCS J3410Injection, hydroxyzine hcl, up to 25 mg
HCPCS J3411Injection, thiamine hcl, 100 mg
HCPCS J3415Injection, pyridoxine hcl, 100 mg
HCPCS J3420Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
HCPCS J3430Injection, phytonadione (vitamin k), per 1 mg
HCPCS J3465Injection, voriconazole, 10 mg
HCPCS J3470Injection, hyaluronidase, up to 150 units
HCPCS J3471Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
HCPCS J3472Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
HCPCS J3473Injection, hyaluronidase, recombinant, 1 usp unit
HCPCS J3475Injection, magnesium sulfate, per 500 mg
HCPCS J3480Injection, potassium chloride, per 2 meq
HCPCS J3485Injection, zidovudine, 10 mg
HCPCS J3486Injection, ziprasidone mesylate, 10 mg
HCPCS J3487Injection, zoledronic acid (zometa), 1 mg
HCPCS J3488Injection, zoledronic acid (reclast), 1 mg
HCPCS J3490Unclassified drugs
HCPCS J3520Edetate disodium, per 150 mg
HCPCS J3530Nasal vaccine inhalation
HCPCS J3535Drug administered through a metered dose inhaler
HCPCS J3570Laetrile, amygdalin, vitamin b17
HCPCS J3590Unclassified biologics
HCPCS J7030Infusion, normal saline solution , 1000 cc
HCPCS J7040Infusion, normal saline solution, sterile (500 ml = 1 unit)
HCPCS J70425% dextrose/normal saline (500 ml = 1 unit)
HCPCS J7050Infusion, normal saline solution, 250 cc
HCPCS J7051STERILE SALINE OR WATER, UP TO 5 CC
HCPCS J70605% dextrose/water (500 ml = 1 unit)
HCPCS J7070Infusion, d5w, 1000 cc
HCPCS J7100Infusion, dextran 40, 500 ml
HCPCS J7110Infusion, dextran 75, 500 ml
HCPCS J7120Ringers lactate infusion, up to 1000 cc
HCPCS J7130Hypertonic saline solution, 50 or 100 meq, 20 cc vial
HCPCS J7131Hypertonic saline solution, 1 ml
HCPCS J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
HCPCS J7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.
HCPCS J7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
HCPCS J7184Injection, von willebrand factor complex (human), wilate, per 100 iu vwf:rco
HCPCS J7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
HCPCS J7186Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
HCPCS J7187Injection, von willebrand factor complex (humate-p), per iu vwf:rco
HCPCS J7188Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
HCPCS J7189Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
HCPCS J7190Factor viii (antihemophilic factor, human) per i.u.
HCPCS J7191Factor viii (antihemophilic factor (porcine)), per i.u.
HCPCS J7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
HCPCS J7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
HCPCS J7194Factor ix, complex, per i.u.
HCPCS J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
HCPCS J7196Injection, antithrombin recombinant, 50 i.u.
HCPCS J7197Antithrombin iii (human), per i.u.
HCPCS J7198Anti-inhibitor, per i.u.
HCPCS J7199Hemophilia clotting factor, not otherwise classified
HCPCS J7300Intrauterine copper contraceptive
HCPCS J7302Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
HCPCS J7303Contraceptive supply, hormone containing vaginal ring, each
HCPCS J7304Contraceptive supply, hormone containing patch, each
HCPCS J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
HCPCS J7307Etonogestrel (contraceptive) implant system, including implant and supplies
HCPCS J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
HCPCS J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
HCPCS J7310Ganciclovir, 4.5 mg, long-acting implant
HCPCS J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
HCPCS J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
HCPCS J7315Mitomycin, ophthalmic, 0.2 mg
HCPCS J7317SODIUM HYALURONATE, PER 20 TO 25 MG DOSE FOR INTRA-ARTICULAR INJECTION
HCPCS J7319HYALURONAN (SODIUM HYALURONATE) OR DERIVATIVE, INTRA-ARTICULAR INJECTION, PER INJECTION
HCPCS J7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
HCPCS J7321Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
HCPCS J7322Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
HCPCS J7323Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
HCPCS J7324Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
HCPCS J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
HCPCS J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
HCPCS J7330Autologous cultured chondrocytes, implant
HCPCS J7335Capsaicin 8% patch, per 10 square centimeters
HCPCS J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
HCPCS J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
HCPCS J7346DERMAL (SUBSTITUTE) TISSUE OF HUMAN ORIGIN, INJECTABLE, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, BUT WITHOUT METABOLICALLY ACTIVE ELEMENTS, 1 CC
HCPCS J7347DERMAL (SUBSTITUTE) TISSUE OF NONHUMAN ORIGIN, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, WITHOUT METABOLICALLY ACTIVE ELEMENTS (INTEGRA MATRIX), PER SQUARE CENTIMETER
HCPCS J7348DERMAL (SUBSTITUTE) TISSUE OF NONHUMAN ORIGIN, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, WITHOUT METABOLICALLY ACTIVE ELEMENTS (TISSUEMEND), PER SQUARE CENTIMETER
HCPCS J7349DERMAL (SUBSTITUTE) TISSUE OF NONHUMAN ORIGIN, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, WITHOUT METABOLICALLY ACTIVE ELEMENTS (PRIMATRIX), PER SQUARE CENTIMETER
HCPCS J7350DERMAL (SUBSTITUTE) TISSUE OF HUMAN ORIGIN, INJECTABLE, WITH OR WITHOUT OTHER BIOENGINEERED OR PROCESSED ELEMENTS, BUT WITHOUT METABOLIZED ACTIVE ELEMENTS, PER 10 MG
HCPCS J7500Azathioprine, oral, 50 mg
HCPCS J7501Azathioprine, parenteral, 100 mg
HCPCS J7502Cyclosporine, oral, 100 mg
HCPCS J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
HCPCS J7505Muromonab-cd3, parenteral, 5 mg
HCPCS J7506Prednisone, oral, per 5 mg
HCPCS J7507Tacrolimus, immediate release, oral, 1 mg
HCPCS J7509Methylprednisolone oral, per 4 mg
HCPCS J7510Prednisolone oral, per 5 mg
HCPCS J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
HCPCS J7513Daclizumab, parenteral, 25 mg
HCPCS J7515Cyclosporine, oral, 25 mg
HCPCS J7516Injection, cyclosporine, 250 mg
HCPCS J7517Mycophenolate mofetil, oral, 250 mg
HCPCS J7518Mycophenolic acid, oral, 180 mg
HCPCS J7520Sirolimus, oral, 1 mg
HCPCS J7525Tacrolimus, parenteral, 5 mg
HCPCS J7527Everolimus, oral, 0.25 mg
HCPCS J7599Immunosuppressive drug, not otherwise classified
HCPCS J7602ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS J7603ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
HCPCS J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
HCPCS J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
HCPCS J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
HCPCS J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
HCPCS J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
HCPCS J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
HCPCS J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
HCPCS J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
HCPCS J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
HCPCS J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
HCPCS J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
HCPCS J7616ALBUTEROL, UP TO 5 MG AND IPRATROPIUM BROMIDE, UP TO 1 MG, COMPOUNDED INHALATION SOLUTION, ADMINISTERED THROUGH DME
HCPCS J7617LEVALBUTEROL, UP TO 2.5 MG AND IPRATROPIUM BROMIDE, UP TO 1 MG, COMPOUNDED INHALATION SOLUTION, ADMINISTERED THROUGH DME
HCPCS J7618ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS J7619ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
HCPCS J7621ALBUTEROL, ALL FORMULATIONS, INCLUDING SEPARATED ISOMERS, UP TO 5 MG (ALBUTEROL) OR 2.5 MG (LEVOALBUTEROL), AND IPRATROPIUM BROMIDE, UP TO 1 MG, COMPOUNDED INHALATION SOLUTION, ADMINISTERED THROUGH DME
HCPCS J7622Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7624Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
HCPCS J7627Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
HCPCS J7628Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7629Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7631Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
HCPCS J7632Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
HCPCS J7633Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
HCPCS J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
HCPCS J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
HCPCS J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
HCPCS J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
HCPCS J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
HCPCS J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
HCPCS J7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
HCPCS J7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
HCPCS J7659Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
HCPCS J7660Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7665Mannitol, administered through an inhaler, 5 mg
HCPCS J7667Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
HCPCS J7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
HCPCS J7669Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
HCPCS J7670Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
HCPCS J7674Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
HCPCS J7676Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
HCPCS J7680Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
HCPCS J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
HCPCS J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
HCPCS J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
HCPCS J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
HCPCS J7699Noc drugs, inhalation solution administered through dme
HCPCS J7799Noc drugs, other than inhalation drugs, administered through dme
HCPCS J8498Antiemetic drug, rectal/suppository, not otherwise specified
HCPCS J8499Prescription drug, oral, non chemotherapeutic, nos
HCPCS J8501Aprepitant, oral, 5 mg
HCPCS J8510Busulfan; oral, 2 mg
HCPCS J8515Cabergoline, oral, 0.25 mg
HCPCS J8520Capecitabine, oral, 150 mg
HCPCS J8521Capecitabine, oral, 500 mg
HCPCS J8530Cyclophosphamide; oral, 25 mg
HCPCS J8540Dexamethasone, oral, 0.25 mg
HCPCS J8560Etoposide; oral, 50 mg
HCPCS J8561Everolimus, oral, 0.25 mg
HCPCS J8562Fludarabine phosphate, oral, 10 mg
HCPCS J8565Gefitinib, oral, 250 mg
HCPCS J8597Antiemetic drug, oral, not otherwise specified
HCPCS J8600Melphalan; oral, 2 mg
HCPCS J8610Methotrexate; oral, 2.5 mg
HCPCS J8650Nabilone, oral, 1 mg
HCPCS J8700Temozolomide, oral, 5 mg
HCPCS J8705Topotecan, oral, 0.25 mg
HCPCS J8999Prescription drug, oral, chemotherapeutic, nos
HCPCS J9000Injection, doxorubicin hydrochloride, 10 mg
HCPCS J9001Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
HCPCS J9002Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
HCPCS J9010Injection, alemtuzumab, 10 mg
HCPCS J9015Injection, aldesleukin, per single use vial
HCPCS J9017Injection, arsenic trioxide, 1 mg
HCPCS J9019Injection, asparaginase (erwinaze), 1,000 iu
HCPCS J9020Injection, asparaginase, not otherwise specified, 10,000 units
HCPCS J9025Injection, azacitidine, 1 mg
HCPCS J9027Injection, clofarabine, 1 mg
HCPCS J9031Bcg (intravesical) per instillation
HCPCS J9033Injection, bendamustine hydrochloride, 1 mg
HCPCS J9035Injection, bevacizumab, 10 mg
HCPCS J9040Injection, bleomycin sulfate, 15 units
HCPCS J9041Injection, bortezomib, 0.1 mg
HCPCS J9042Injection, brentuximab vedotin, 1 mg
HCPCS J9043Injection, cabazitaxel, 1 mg
HCPCS J9045Injection, carboplatin, 50 mg
HCPCS J9050Injection, carmustine, 100 mg
HCPCS J9055Injection, cetuximab, 10 mg
HCPCS J9060Injection, cisplatin, powder or solution, 10 mg
HCPCS J9062Cisplatin, 50 mg
HCPCS J9065Injection, cladribine, per 1 mg
HCPCS J9070Cyclophosphamide, 100 mg
HCPCS J9080Cyclophosphamide, 200 mg
HCPCS J9090Cyclophosphamide, 500 mg
HCPCS J9091Cyclophosphamide, 1.0 gram
HCPCS J9092Cyclophosphamide, 2.0 gram
HCPCS J9093Cyclophosphamide, lyophilized, 100 mg
HCPCS J9094Cyclophosphamide, lyophilized, 200 mg
HCPCS J9095Cyclophosphamide, lyophilized, 500 mg
HCPCS J9096Cyclophosphamide, lyophilized, 1.0 gram
HCPCS J9097Cyclophosphamide, lyophilized, 2.0 gram
HCPCS J9098Injection, cytarabine liposome, 10 mg
HCPCS J9100Injection, cytarabine, 100 mg
HCPCS J9110Injection, cytarabine, 500 mg
HCPCS J9120Injection, dactinomycin, 0.5 mg
HCPCS J9130Dacarbazine, 100 mg
HCPCS J9140Dacarbazine, 200 mg
HCPCS J9150Injection, daunorubicin, 10 mg
HCPCS J9151Injection, daunorubicin citrate, liposomal formulation, 10 mg
HCPCS J9155Injection, degarelix, 1 mg
HCPCS J9160Injection, denileukin diftitox, 300 micrograms
HCPCS J9165Injection, diethylstilbestrol diphosphate, 250 mg
HCPCS J9170INJECTION, DOCETAXEL, 20 MG
HCPCS J9171Injection, docetaxel, 1 mg
HCPCS J9175Injection, elliotts' b solution, 1 ml
HCPCS J9178Injection, epirubicin hcl, 2 mg
HCPCS J9179Injection, eribulin mesylate, 0.1 mg
HCPCS J9181Injection, etoposide, 10 mg
HCPCS J9182ETOPOSIDE, 100 MG
HCPCS J9185Injection, fludarabine phosphate, 50 mg
HCPCS J9190Injection, fluorouracil, 500 mg
HCPCS J9200Injection, floxuridine, 500 mg
HCPCS J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
HCPCS J9202Goserelin acetate implant, per 3.6 mg
HCPCS J9206Injection, irinotecan, 20 mg
HCPCS J9207Injection, ixabepilone, 1 mg
HCPCS J9208Injection, ifosfamide, 1 gram
HCPCS J9209Injection, mesna, 200 mg
HCPCS J9211Injection, idarubicin hydrochloride, 5 mg
HCPCS J9212Injection, interferon alfacon-1, recombinant, 1 microgram
HCPCS J9213Injection, interferon, alfa-2a, recombinant, 3 million units
HCPCS J9214Injection, interferon, alfa-2b, recombinant, 1 million units
HCPCS J9215Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
HCPCS J9216Injection, interferon, gamma 1-b, 3 million units
HCPCS J9217Leuprolide acetate (for depot suspension), 7.5 mg
HCPCS J9218Leuprolide acetate, per 1 mg
HCPCS J9219Leuprolide acetate implant, 65 mg
HCPCS J9225Histrelin implant (vantas), 50 mg
HCPCS J9226Histrelin implant (supprelin la), 50 mg
HCPCS J9228Injection, ipilimumab, 1 mg
HCPCS J9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
HCPCS J9245Injection, melphalan hydrochloride, not otherwise specified, 50 mg
HCPCS J9250Methotrexate sodium, 5 mg
HCPCS J9260Injection, methotrexate sodium, 50 mg
HCPCS J9261Injection, nelarabine, 50 mg
HCPCS J9263Injection, oxaliplatin, 0.5 mg
HCPCS J9264Injection, paclitaxel protein-bound particles, 1 mg
HCPCS J9265Injection, paclitaxel, 30 mg
HCPCS J9266Injection, pegaspargase, per single dose vial
HCPCS J9268Injection, pentostatin, 10 mg
HCPCS J9270Injection, plicamycin, 2.5 mg
HCPCS J9280Injection, mitomycin, 5 mg
HCPCS J9290Mitomycin, 20 mg
HCPCS J9291Mitomycin, 40 mg
HCPCS J9293Injection, mitoxantrone hydrochloride, per 5 mg
HCPCS J9300Injection, gemtuzumab ozogamicin, 5 mg
HCPCS J9302Injection, ofatumumab, 10 mg
HCPCS J9303Injection, panitumumab, 10 mg
HCPCS J9305Injection, pemetrexed, not otherwise specified, 10 mg
HCPCS J9307Injection, pralatrexate, 1 mg
HCPCS J9310Injection, rituximab, 100 mg
HCPCS J9315Injection, romidepsin, 1 mg
HCPCS J9320Injection, streptozocin, 1 gram
HCPCS J9328Injection, temozolomide, 1 mg
HCPCS J9330Injection, temsirolimus, 1 mg
HCPCS J9340Injection, thiotepa, 15 mg
HCPCS J9350Injection, mosunetuzumab-axgb, 1 mg
HCPCS J9351Injection, topotecan, 0.1 mg
HCPCS J9355Injection, trastuzumab, excludes biosimilar, 10 mg
HCPCS J9357Injection, valrubicin, intravesical, 200 mg
HCPCS J9360Injection, vinblastine sulfate, 1 mg
HCPCS J9370Vincristine sulfate, 1 mg
HCPCS J9375Vincristine sulfate, 2 mg
HCPCS J9380Injection, teclistamab-cqyv, 0.5 mg
HCPCS J9390Injection, vinorelbine tartrate, 10 mg
HCPCS J9395Injection, fulvestrant, 25 mg
HCPCS J9600Injection, porfimer sodium, 75 mg
HCPCS J9999Not otherwise classified, antineoplastic drugs
HCPCS K0415PRESCRIPTION ANTIEMETIC DRUG, ORAL, PER 1 MG, FOR USE IN CONJUNCTION WITH ORAL ANTI-CANCER DRUG, NOT OTHERWISE SPECIFIED
HCPCS K0416PRESCRIPTION ANTIEMETIC DRUG, RECTAL, PER 1 MG, FOR USE IN CONJUNCTION WITH ORAL ANTI-CANCER DRUG, NOT OTHERWISE SPECIFIED
HCPCS K0672Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each
HCPCS M0075Cellular therapy
HCPCS Q0136INJECTION, EPOETIN ALPHA, (FOR NON ESRD USE), PER 1000 UNITS
HCPCS Q0137INJECTION, DARBEPOETIN ALFA, 1 MCG (NON-ESRD USE)
HCPCS Q0144Azithromycin dihydrate, oral, capsules/powder, 1 gram
HCPCS Q0163Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
HCPCS Q0164Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0165Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0166Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
HCPCS Q0167Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0168Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0169Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0170Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0171Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0172Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0173Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0174Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0175Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0176Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0177Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0178Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0179Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0180Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
HCPCS Q0181Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Q0510Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
HCPCS Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
HCPCS Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
HCPCS Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 days
HCPCS Q0514Pharmacy dispensing fee for inhalation drug(s); per 90 days
HCPCS Q0515Injection, sermorelin acetate, 1 microgram
HCPCS Q2001ORAL, CABERGOLINE, 0.5 MG
HCPCS Q2002INJECTION, ELLIOTTS B SOLUTION, PER ML
HCPCS Q2003INJECTION, APROTININ, 10,000 KIU
HCPCS Q2005INJECTION, CORTICORELIN OVINE TRIFLUTATE, PER DOSE
HCPCS Q2006INJECTION, DIGOXIN IMMUNE FAB (OVINE), PER VIAL
HCPCS Q2007INJECTION, ETHANOLAMINE OLEATE, 100 MG
HCPCS Q2008INJECTION, FOMEPIZOLE, 15 MG
HCPCS Q2009Injection, fosphenytoin, 50 mg phenytoin equivalent
HCPCS Q2011INJECTION, HEMIN, PER 1 MG
HCPCS Q2012INJECTION, PEGADEMASE BOVINE, 25 IU
HCPCS Q2013INJECTION, PENTASTARCH, 10% SOLUTION, PER 100 ML
HCPCS Q2014INJECTION, SERMORELIN ACETATE, 0.5 MG
HCPCS Q2017Injection, teniposide, 50 mg
HCPCS Q2018INJECTION, UROFOLLITROPIN, 75 IU
HCPCS Q2019INJECTION, BASILIXIMAB, 20 MG
HCPCS Q2020INJECTION, HISTRELIN ACETATE, 10 MCG
HCPCS Q2021INJECTION, LEPIRUDIN, 50 MG
HCPCS Q2022VON WILLEBRAND FACTOR COMPLEX, HUMAN, PER IU
HCPCS Q2023INJECTION, FACTOR VIII (ANTIHEMOPHILIC FACTOR, RECOMBINANT) (XYNTHA), PER I.U.
HCPCS Q2024INJECTION, BEVACIZUMAB, 0.25 MG
HCPCS Q2025Fludarabine phosphate, oral, 1 mg
HCPCS Q2026Injection, radiesse, 0.1 ml
HCPCS Q2027Injection, sculptra, 0.1 ml
HCPCS Q2040Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
HCPCS Q2041Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
HCPCS Q2042Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
HCPCS Q2043Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
HCPCS Q2044Injection, belimumab, 10 mg
HCPCS Q2045Injection, human fibrinogen concentrate, 1 mg
HCPCS Q2046Injection, aflibercept, 1 mg
HCPCS Q2047Injection, peginesatide, 0.1 mg (for esrd on dialysis)
HCPCS Q2048Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
HCPCS Q2049Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
HCPCS Q3025Injection, interferon beta-1a, 11 mcg for intramuscular use
HCPCS Q3026Injection, interferon beta-1a, 11 mcg for subcutaneous use
HCPCS Q4054INJECTION, DARBEPOETIN ALFA, 1 MCG (FOR ESRD ON DIALYSIS)
HCPCS Q4055INJECTION, EPOETIN ALFA, 1000 UNITS (FOR ESRD ON DIALYSIS)
HCPCS Q4074Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
HCPCS Q4075INJECTION, ACYCLOVIR, 5 MG
HCPCS Q4076INJECTION, DOPAMINE HCL, 40 MG
HCPCS Q4077INJECTION, TREPROSTINIL, 1 MG
HCPCS Q4079INJECTION, NATALIZUMAB, 1 MG
HCPCS Q4081Injection, epoetin alfa, 100 units (for esrd on dialysis)
HCPCS Q4082Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
HCPCS Q4083HYALURONAN OR DERIVATIVE, HYALGAN OR SUPARTZ, FOR INTRA-ARTICULAR INJECTION, PER DOSE
HCPCS Q4084HYALURONAN OR DERIVATIVE, SYNVISC, FOR INTRA-ARTICULAR INJECTION, PER DOSE
HCPCS Q4085HYALURONAN OR DERIVATIVE, EUFLEXXA, FOR INTRA-ARTICULAR INJECTION, PER DOSE
HCPCS Q4086HYALURONAN OR DERIVATIVE, ORTHOVISC, FOR INTRA-ARTICULAR INJECTION, PER DOSE
HCPCS Q4087INJECTION, IMMUNE GLOBULIN, (OCTAGAM), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
HCPCS Q4088INJECTION, IMMUNE GLOBULIN, (GAMMAGARD LIQUID), INTRAVENOUS, NON-LYOPHILIZED, (E.G. LIQUID), 500 MG
HCPCS Q4089INJECTION, RHO(D) IMMUNE GLOBULIN (HUMAN), (RHOPHYLAC), INTRAMUSCULAR OR INTRAVENOUS, 100 IU
HCPCS Q4090INJECTION, HEPATITIS B IMMUNE GLOBULIN (HEPAGAM B), INTRAMUSCULAR, 0.5 ML
HCPCS Q4091INJECTION, IMMUNE GLOBULIN, (FLEBOGAMMA), INTRAVENOUS, NON-LYOPHILIZED, (E.G. LIQUID), 500 MG
HCPCS Q4092INJECTION, IMMUNE GLOBULIN, (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
HCPCS Q4093ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS Q4094ALBUTEROL, ALL FORMULATIONS INCLUDING SEPARATED ISOMERS, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, PER 1 MG (ALBUTEROL) OR PER 0.5 MG (LEVALBUTEROL)
HCPCS Q4095INJECTION, ZOLEDRONIC ACID (RECLAST), 1 MG
HCPCS Q4096INJECTION, VON WILLEBRAND FACTOR COMPLEX, HUMAN, RISTOCETIN COFACTOR (NOT OTHERWISE SPECIFIED), PER I.U. VWF: RCO
HCPCS Q4097INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
HCPCS Q4098INJECTION, IRON DEXTRAN, 50 MG
HCPCS Q4099FORMOTEROL FUMARATE, INHALATION SOLUTION, FDA APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 20 MICROGRAMS
HCPCS Q9941INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, LYOPHILIZED, 1G
HCPCS Q9942INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, LYOPHILIZED, 10 MG
HCPCS Q9943INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, NON-LYOPHILIZED, 1G
HCPCS Q9944INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, NON-LYOPHILIZED, 10 MG
HCPCS Q9952INJECTION, GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENT, PER ML
HCPCS Q9953Injection, iron-based magnetic resonance contrast agent, per ml
HCPCS Q9955Injection, perflexane lipid microspheres, per ml
HCPCS Q9956Injection, octafluoropropane microspheres, per ml
HCPCS Q9957Injection, perflutren lipid microspheres, per ml
HCPCS S0012Butorphanol tartrate, nasal spray, 25 mg
HCPCS S0014Tacrine hydrochloride, 10 mg
HCPCS S0016INJECTION, AMIKACIN SULFATE, 500 MG
HCPCS S0017Injection, aminocaproic acid, 5 grams
HCPCS S0020Injection, bupivicaine hydrochloride, 30 ml
HCPCS S0021Injection, cefoperazone sodium, 1 gram
HCPCS S0023Injection, cimetidine hydrochloride, 300 mg
HCPCS S0028Injection, famotidine, 20 mg
HCPCS S0030Injection, metronidazole, 500 mg
HCPCS S0032Injection, nafcillin sodium, 2 grams
HCPCS S0034Injection, ofloxacin, 400 mg
HCPCS S0039Injection, sulfamethoxazole and trimethoprim, 10 ml
HCPCS S0040Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
HCPCS S0071INJECTION, ACYCLOVIR SODIUM, 50 MG
HCPCS S0072INJECTION, AMIKACIN SULFATE, 100 MG
HCPCS S0073Injection, aztreonam, 500 mg
HCPCS S0074Injection, cefotetan disodium, 500 mg
HCPCS S0077Injection, clindamycin phosphate, 300 mg
HCPCS S0078Injection, fosphenytoin sodium, 750 mg
HCPCS S0080Injection, pentamidine isethionate, 300 mg
HCPCS S0081Injection, piperacillin sodium, 500 mg
HCPCS S0088Imatinib, 100 mg
HCPCS S0090Sildenafil citrate, 25 mg
HCPCS S0091Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)
HCPCS S0092Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)
HCPCS S0093Injection, morphine sulfate, 500 mg (loading dose for infusion pump)
HCPCS S0104Zidovudine, oral, 100 mg
HCPCS S0106Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
HCPCS S0107INJECTION, OMALIZUMAB, 25 MG
HCPCS S0108Mercaptopurine, oral, 50 mg
HCPCS S0109Methadone, oral, 5 mg
HCPCS S0114INJECTION, TREPROSTINIL SODIUM, 0.5 MG
HCPCS S0115BORTEZOMIB, 3.5 MG
HCPCS S0116BEVACIZUMAB, 100 MG
HCPCS S0117Tretinoin, topical, 5 grams
HCPCS S0118INJECTION, ZICONOTIDE, FOR INTRATHECAL INFUSION, 1 MCG
HCPCS S0119Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
HCPCS S0122Injection, menotropins, 75 iu
HCPCS S0126Injection, follitropin alfa, 75 iu
HCPCS S0128Injection, follitropin beta, 75 iu
HCPCS S0132Injection, ganirelix acetate, 250 mcg
HCPCS S0133HISTRELIN, IMPLANT, 50 MG
HCPCS S0136Clozapine, 25 mg
HCPCS S0137Didanosine (ddi), 25 mg
HCPCS S0138Finasteride, 5 mg
HCPCS S0139Minoxidil, 10 mg
HCPCS S0140Saquinavir, 200 mg
HCPCS S0141ZALCITABINE (DDC), 0.375 MG
HCPCS S0142Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg
HCPCS S0143AZTREONAM, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER
HCPCS S0145Injection, pegylated interferon alfa-2a, 180 mcg per ml
HCPCS S0146Injection, pegylated interferon alfa-2b, 10 mcg per 0.5 ml
HCPCS S0147INJECTION, ALGLUCOSIDASE ALFA, 20 MG
HCPCS S0148Injection, pegylated interferon alfa-2b, 10 mcg
HCPCS S0156Exemestane, 25 mg
HCPCS S0157Becaplermin gel 0.01%, 0.5 gm
HCPCS S0158INJECTION, LARONIDASE, 0.58 MG
HCPCS S0159INJECTION, AGALSIDASE BETA, 35 MG
HCPCS S0160Dextroamphetamine sulfate, 5 mg
HCPCS S0161Calcitrol, 0.25 mg
HCPCS S0162INJECTION, EFALIZUMAB, 125 MG
HCPCS S0163INJECTION, RISPERIDONE, LONG ACTING, 12.5 MG
HCPCS S0164Injection, pantoprazole sodium, 40 mg
HCPCS S0165INJECTION, ABARELIX, 100 MG
HCPCS S0166Injection, olanzapine, 2.5 mg
HCPCS S0167INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG
HCPCS S0168INJECTION, AZACITIDINE, 100 MG
HCPCS S0169Calcitrol, 0.25 microgram
HCPCS S0170Anastrozole, oral, 1 mg
HCPCS S0171Injection, bumetanide, 0.5 mg
HCPCS S0172Chlorambucil, oral, 2 mg
HCPCS S0173DEXAMETHASONE, ORAL, 4MG
HCPCS S0174Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)
HCPCS S0175Flutamide, oral, 125 mg
HCPCS S0176Hydroxyurea, oral, 500 mg
HCPCS S0177Levamisole hydrochloride, oral, 50 mg
HCPCS S0178Lomustine, oral, 10 mg
HCPCS S0179Megestrol acetate, oral, 20 mg
HCPCS S0180ETONOGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM, INCLUDING IMPLANTS AND SUPPLIES
HCPCS S0181Ondansetron hydrochloride, oral, 4mg (for circumstances falling under the medicare statute, use q0179)
HCPCS S0182Procarbazine hydrochloride, oral, 50 mg
HCPCS S0183Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)
HCPCS S0187Tamoxifen citrate, oral, 10 mg
HCPCS S0189Testosterone pellet, 75 mg
HCPCS S0190Mifepristone, oral, 200 mg
HCPCS S0191Misoprostol, oral, 200 mcg
HCPCS S0194Dialysis/stress vitamin supplement, oral, 100 capsules
HCPCS S0197Prenatal vitamins, 30-day supply
HCPCS S0198INJECTION, PEGAPTANIB SODIUM, 0.3 MG
HCPCS S1090Mometasone furoate sinus implant, 370 micrograms
HCPCS S2112Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)
HCPCS S2113ARTHROSCOPY, KNEE, SURGICAL FOR IMPLANTATION OF CULTURED ANALOGOUS CHONDROCYTES
HCPCS S2135NEUROLYSIS, BY INJECTION, OF METATARSAL NEUROMA/INTERDIGITAL NEURITIS, ANY
HCPCS S2202Echosclerotherapy
HCPCS S3722Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
HCPCS S4990Nicotine patches, legend
HCPCS S4991Nicotine patches, non-legend
HCPCS S4993Contraceptive pills for birth control
HCPCS S4995Smoking cessation gum
HCPCS S5000Prescription drug, generic
HCPCS S5001Prescription drug, brand name
HCPCS S50125% dextrose with potassium chloride, 1000 ml
HCPCS S50145% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml
HCPCS S5550Insulin, rapid onset, 5 units
HCPCS S5551Insulin, most rapid onset (lispro or aspart); 5 units
HCPCS S5552Insulin, intermediate acting (nph or lente); 5 units
HCPCS S5553Insulin, long acting; 5 units
HCPCS T1502Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit
HCPCS T1503Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit

CPT Code information is available to subscribers and includes the CPT code number, short description, long description, guidelines and more.  CPT code information is copyright by the AMA.

Access to this feature is available in the following products:
  • Find-A-Code Essentials
  • Find-A-Code Professional/Premium/Elite
  • Find-A-Code Facility Base/Plus/Complete
CPT Code information is available to subscribers and includes the CPT code number, short description, long description, guidelines and more.  CPT code information is copyright by the AMA.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.